Best Treatment for Meibomian Gland Dysfunction- Azithromycin
Best Treatment for Meibomian Gland Dysfunction - Azithromycine
New Research Indicates Azithromycin is more effective than Doxycycline for Meibomian Gland Dysfunction and Blepharitis.
There are several studies concerning the use of topical azithromycin in ocular surface diseases.
New research at the University of Louisville compared the effectiveness of topical azithromycin versus oral doxycycline therapy in meibomian gland dysfunction (and Blepharitis) Twenty-two (22) subjects were treated with topical azithromucin solution for one month and seven subjects were treated with oral doxycycline for two (20 months. The study concluded that while both topical azithromycin and oral doxycycline improved clinical signs and symptoms of meibomian gland dysfunction, the "response to azithromycin is more rapid and more robust than doxycycline."
Another research study from the Ohio State University evaluated the efficacy of a four-week treatment with topical 1.0% azithromycin solution versus rewetting drops in patients with contact lens related dry eye. Patients are able to wear contact lenses two-hours longer throughout the four-week study period when azithromycin solution was use.
Blepharitis being a chronic inflammation of the eye lid goes hand in hand with Meibomian Gland Dysfunction and chronic dry eyes. Here is how TheraLife Eye can help!
How can TheraLife Eye Help?
TheraLife Eye is uniquely formulated to restore normal cell functions to tear secretion glands intra-cellularly for sustainable, long lasting relief. Clinically proven to work for 80% of first time users. Antibiotics help reduce inflammation, however, inflammation shuts down tear secretion glands. Use TheraLife Eye to restore normal tear function.